Same Indication

Pembrolizumab vs Sertraline

Pembrolizumab vs Sertraline: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Sertraline.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Sertraline: Selective serotonin reuptake inhibitor (SSRI).

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Sertraline — 26 hours.

Chemical Properties

Molecular Formula: Sertraline — C17H17Cl2N.

Molecular Weight: Sertraline — 306.2290 g/mol.

Type: Pembrolizumab — Antibody; Sertraline — Small molecule.